Access Pharma Initiates US MuGard Sampling Program with Leading Oncology Groups
DALLAS and NEW YORK, June 15 /PRNewswire-FirstCall/ — ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has initiated a broad-scale MuGard Centers-of-Excellence Sampling Program with leading oncology networks for its lead product, MuGard, a FDA-approved product for the management of …

Read more on redOrbit